Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Scholar Rock Holding Corp | 10%+ Owner | Common Stock | 11.3M | $179M | $15.93 | Oct 12, 2023 | Direct |
Omega Therapeutics, Inc. | 10%+ Owner | Common Stock | 2.27M | $18.2M | $8.00 | Aug 3, 2021 | Direct |
GLYCOMIMETICS INC | 10%+ Owner | Common Stock | 6.32M | $1.21M | $0.19 | Aug 8, 2024 | Direct |
Omega Therapeutics, Inc. | 10%+ Owner | Series C Convertible Preferred Stock | 0 | Aug 3, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GLYC | GLYCOMIMETICS INC | Aug 7, 2024 | 2 | -$61.2K | 4 | Aug 9, 2024 | 10%+ Owner |
GLYC | GLYCOMIMETICS INC | Aug 5, 2024 | 2 | -$41.2K | 4 | Aug 7, 2024 | 10%+ Owner |
GLYC | GLYCOMIMETICS INC | Aug 1, 2024 | 2 | -$71.1K | 4 | Aug 5, 2024 | 10%+ Owner |
GLYC | GLYCOMIMETICS INC | Jul 26, 2024 | 3 | -$315K | 4 | Jul 30, 2024 | 10%+ Owner |
SRRK | Scholar Rock Holding Corp | Oct 12, 2023 | 2 | $15.1M | 4 | Oct 16, 2023 | 10%+ Owner |
SRRK | Scholar Rock Holding Corp | Apr 28, 2023 | 1 | $203K | 4 | May 2, 2023 | 10%+ Owner |
GLYC | GLYCOMIMETICS INC | Feb 24, 2023 | 1 | $170K | 4 | Feb 28, 2023 | 10%+ Owner |
GLYC | GLYCOMIMETICS INC | Feb 21, 2023 | 3 | $712K | 4 | Feb 23, 2023 | 10%+ Owner |
GLYC | GLYCOMIMETICS INC | Feb 15, 2023 | 3 | $3.03M | 4 | Feb 17, 2023 | 10%+ Owner |
GLYC | GLYCOMIMETICS INC | Feb 9, 2023 | 1 | $37.1K | 4 | Feb 13, 2023 | 10%+ Owner |
GLYC | GLYCOMIMETICS INC | Feb 9, 2023 | 0 | $0 | 3 | Feb 13, 2023 | 10%+ Owner |
SRRK | Scholar Rock Holding Corp | Jan 9, 2023 | 1 | -$10.4K | 4 | Jan 11, 2023 | 10%+ Owner |
SRRK | Scholar Rock Holding Corp | Jan 5, 2023 | 1 | $455K | 4 | Jan 9, 2023 | 10%+ Owner |
SRRK | Scholar Rock Holding Corp | Oct 25, 2022 | 1 | $1.05M | 4 | Oct 27, 2022 | 10%+ Owner |
SRRK | Scholar Rock Holding Corp | Oct 3, 2022 | 2 | $760K | 4 | Oct 7, 2022 | 10%+ Owner |
SRRK | Scholar Rock Holding Corp | Jun 22, 2022 | 0 | $0 | 3 | Jun 24, 2022 | 10%+ Owner |
OMGA | Omega Therapeutics, Inc. | Jul 30, 2021 | 4 | $16.1M | 4 | Aug 3, 2021 | 10%+ Owner |
OMGA | Omega Therapeutics, Inc. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | 10%+ Owner |